Patrick Ellsworth

644 total citations
20 papers, 396 citations indexed

About

Patrick Ellsworth is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick Ellsworth has authored 20 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick Ellsworth's work include Hemophilia Treatment and Research (8 papers), Hemoglobinopathies and Related Disorders (7 papers) and Platelet Disorders and Treatments (5 papers). Patrick Ellsworth is often cited by papers focused on Hemophilia Treatment and Research (8 papers), Hemoglobinopathies and Related Disorders (7 papers) and Platelet Disorders and Treatments (5 papers). Patrick Ellsworth collaborates with scholars based in United States, Germany and Italy. Patrick Ellsworth's co-authors include Nigel S. Key, Jacob G. Scott, Rafał Pawliński, Denis F. Noubouossie, Anton Ilich, Javier F. Torres–Roca, Michael W. Henderson, Michael W. Kattan, Jessica Scarborough and Daniel Oliver and has published in prestigious journals such as Blood, PLoS ONE and The Lancet Oncology.

In The Last Decade

Patrick Ellsworth

19 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Ellsworth United States 10 141 117 83 70 53 20 396
Irina Zaidman Israel 13 146 1.0× 50 0.4× 65 0.8× 97 1.4× 73 1.4× 47 438
David Bloxham United Kingdom 11 179 1.3× 156 1.3× 54 0.7× 110 1.6× 48 0.9× 23 452
J. Cush United States 8 103 0.7× 47 0.4× 31 0.4× 47 0.7× 47 0.9× 16 516
Kuang‐Yueh Chiang United States 12 229 1.6× 49 0.4× 37 0.4× 120 1.7× 122 2.3× 31 481
Jurjen Versluis Netherlands 13 240 1.7× 54 0.5× 132 1.6× 120 1.7× 305 5.8× 43 747
Kam Newman United States 11 67 0.5× 28 0.2× 50 0.6× 95 1.4× 115 2.2× 16 363
Hagit Miskin Israel 12 195 1.4× 190 1.6× 45 0.5× 48 0.7× 34 0.6× 24 455
Sai Ravi Pingali United States 14 167 1.2× 64 0.5× 42 0.5× 95 1.4× 212 4.0× 63 529
Koh Izumiyama Japan 13 130 0.9× 38 0.3× 57 0.7× 58 0.8× 124 2.3× 55 609
Étienne Crickx France 12 163 1.2× 66 0.6× 48 0.6× 30 0.4× 44 0.8× 25 421

Countries citing papers authored by Patrick Ellsworth

Since Specialization
Citations

This map shows the geographic impact of Patrick Ellsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Ellsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Ellsworth more than expected).

Fields of papers citing papers by Patrick Ellsworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Ellsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Ellsworth. The network helps show where Patrick Ellsworth may publish in the future.

Co-authorship network of co-authors of Patrick Ellsworth

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Ellsworth. A scholar is included among the top collaborators of Patrick Ellsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Ellsworth. Patrick Ellsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grover, Steven P., Chatphatai Moonla, Michael W. Henderson, et al.. (2025). Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model. Blood Advances. 9(11). 2709–2721. 1 indexed citations
2.
3.
Ellsworth, Patrick, Anton Ilich, Chatphatai Moonla, et al.. (2024). Hypertonicity and/or acidosis induce marked rheological changes under hypoxic conditions in sickle trait red blood cells. British Journal of Haematology. 205(4). 1565–1569. 3 indexed citations
4.
Drygalski, Annette von, Aric Parnes, Evan C. Chen, et al.. (2024). Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort. Blood Advances. 8(22). 5896–5905. 1 indexed citations
5.
Ellsworth, Patrick, et al.. (2024). Emicizumab promotes factor Xa generation on endothelial cells. Journal of Thrombosis and Haemostasis. 22(6). 1605–1615. 1 indexed citations
6.
Ellsworth, Patrick, et al.. (2024). Acquired hemophilia A: a narrative review and management approach in the emicizumab era. Journal of Thrombosis and Haemostasis. 23(3). 824–835. 3 indexed citations
7.
Ellsworth, Patrick & Erica Sparkenbaugh. (2023). Targeting the von Willebrand Factor–ADAMTS-13 axis in sickle cell disease. Journal of Thrombosis and Haemostasis. 21(1). 2–6. 4 indexed citations
8.
Farrokhian, Nathan, Jeff Maltas, Arda Durmaz, et al.. (2022). Measuring competitive exclusion in non–small cell lung cancer. Science Advances. 8(26). eabm7212–eabm7212. 31 indexed citations
9.
Scott, Jacob G., Patrick Ellsworth, Jessica Scarborough, et al.. (2021). Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis. The Lancet Oncology. 22(9). 1221–1229. 90 indexed citations
10.
11.
Ellsworth, Patrick, et al.. (2021). Emicizumab reduces re‐hospitalization for bleeding in acquired haemophilia A. Haemophilia. 27(4). e585–e588. 10 indexed citations
12.
Ellsworth, Patrick & Alice Ma. (2021). Factor-mimetic and rebalancing therapies in hemophilia A and B: the end of factor concentrates?. Hematology. 2021(1). 219–225. 19 indexed citations
13.
Noubouossie, Denis F., Michael W. Henderson, Micah J. Mooberry, et al.. (2020). Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways. Blood. 135(10). 755–765. 66 indexed citations
14.
Sparkenbaugh, Erica, Małgorzata Kasztan, Michael W. Henderson, et al.. (2020). High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease. Journal of Thrombosis and Haemostasis. 18(9). 2329–2340. 9 indexed citations
15.
Ellsworth, Patrick, et al.. (2020). Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort. Blood Advances. 4(24). 6240–6249. 17 indexed citations
16.
Ellsworth, Patrick, Ghaith Habboub, Gino Cioffi, et al.. (2020). A comprehensive epidemiological review of spinal astrocytomas in the United States. Journal of Neurosurgery Spine. 34(2). 303–309. 7 indexed citations
17.
Wilson, Samuel, Patrick Ellsworth, & Nigel S. Key. (2020). Pregnancy in sickle cell trait: what we do and don’t know. British Journal of Haematology. 190(3). 328–335. 16 indexed citations
18.
Faës, Camille, Anton Ilich, Erica Sparkenbaugh, et al.. (2019). Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease. Blood. 133(23). 2529–2541. 52 indexed citations
19.
Ilich, Anton, Denis F. Noubouossie, Michael W. Henderson, et al.. (2019). Development and application of global assays of hyper‐ and hypofibrinolysis. Research and Practice in Thrombosis and Haemostasis. 4(1). 46–53. 24 indexed citations
20.
Becknell, Brian, John David Spencer, Ashley R. Carpenter, et al.. (2013). Expression and Antimicrobial Function of Beta-Defensin 1 in the Lower Urinary Tract. PLoS ONE. 8(10). e77714–e77714. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irina Zaidman Breakdown of academic impact, for papers by David Bloxham Breakdown of academic impact, for papers by J. Cush Breakdown of academic impact, for papers by Kuang‐Yueh Chiang Breakdown of academic impact, for papers by Jurjen Versluis Breakdown of academic impact, for papers by Kam Newman Breakdown of academic impact, for papers by Hagit Miskin Breakdown of academic impact, for papers by Sai Ravi Pingali Breakdown of academic impact, for papers by Koh Izumiyama Breakdown of academic impact, for papers by Étienne Crickx
Rankless by CCL
2026